Journal Home
Search for

Volume 20, Issue 3, Pages 371-379 (March 2010)


View previous. 13 of 24 View next.

Prediction of in-vitro developmental competence of early cleavage-stage mouse embryos with compact time-lapse equipment

Csaba PribenszkyaCorresponding Author Informationemail address, Eszter Losonczib, Miklós Molnárb, Zsolt Langc, Szabolcs Mátyásd, Klára Rajczyd, Katalin Molnárd, Péter Kovácsd, Péter Nagye, Jason Conceicaof, Gábor Vajtag

Received 6 July 2009; received in revised form 3 August 2009; accepted 26 November 2009. published online 21 January 2010.

Abstract 

Single blastocyst transfer is regarded as an efficient way to achieve high pregnancy rates and to avoid multiple pregnancies. Risk of cancellation of transfer due to a lack of available embryos may be reduced by early prediction of blastocyst development. Time-lapse investigation of mouse embryos shows that the time of the first and second cleavage (to the 2- and 3-cell stages, respectively) has a strong predictive value for further development in vitro, while cleavage from the 3-cell to the 4-cell stage has no predictive value. In humans, embryo fragmentation during preimplantation development has been associated with lower pregnancy rates and a higher incidence of developmental abnormalities. Analysis of time-lapse records shows that most fragmentation is reversible in the mouse and is resorbed in an average of 9h. Daily or bi-daily microscopic checks of embryo development, applied routinely in human IVF laboratories, would fail to detect 36 or 72% of these fragmentations, respectively. Fragmentation occurring in a defined time frame has a strong predictive value for in-vitro embryo development. The practical compact system used in the present trial, based on the ‘one camera per patient’ principle, has eliminated the usual disadvantages of time-lapse investigations and is applicable for the routine follow-up of in-vitro embryo development.

Declaration: The authors Csaba Pribenszky, Miklos Molnar and Gabor Vajta are shareholders in the company Cryo-Innovation. The other authors declare no financial or commercial conflicts of interest.

a Department of Animal Breeding and Genetics, Faculty of Veterinary Science, Szent István University, István u. 2, Budapest 1078, Hungary

b ARTechnic Co. Research and Development, Csapó u. 13, Debrecen, Hungary

c Department of Biomathematics and Informatics, Faculty of Veterinary Science, Szent István University, István u. 2, Budapest 1078, Hungary

d Department of Embryology, KAÁLI Institute, Istenhegyi út 54/A, Budapest 1125, Hungary

e Department of Electronics Technology, Faculty of Electrical Engineering and Informatics, Budapest University of Technology and Economics, Budapest, Hungary

f PIVET Medical Centre, 166–168 Cambridge St., Perth, WA, Australia

g Cairns Fertility Centre, 58–60 McLeod St., Cairns, Qld 4870, Australia

Corresponding Author InformationCorresponding author.

 Csaba Pribenszky obtained a DVM degree (1998) and a PhD degree (2005) in the field of assisted reproductive technologies in Budapest, Hungary. Together with Mikos Molnar, he developed and patented the concept of ‘stress for stress tolerance’, utilizing sub-lethal hydrostatic pressure stress treatment to gametes, embryos, other cells and tissues in order to improve cell survival during subsequent procedures (e.g. cryopreservation, SCNT). His current focus is the application of the above method to human oocyte vitrification and the effect of different environmental factors on in-vitro embryo developmental dynamics and embryo fragmentation.

PII: S1472-6483(09)00284-3

doi:10.1016/j.rbmo.2009.12.007


View previous. 13 of 24 View next.